The novel therapy of the medication represents a major development in the care of type 2 diabetes. Different to existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide411350.blogdomago.com/40470886/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment